Thermo Fisher Scientific Inc (TMO) is currently trading at $675.00. Based on 27 Wall Street analysts, the average target price is $653.11, implying a 3.2% downside. The consensus recommendation is BUY.

Over the past 30 days, the feed records 1 target raise and 0 target cuts for TMO. Over the past 90 days, the feed records 5 target raises and 1 target cut for TMO.

TMO

Thermo Fisher Scientific Inc

HealthcareOpinion: buy

Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).

Price (USD)

$675.00

Consensus target price range

Low–high band from analyst PT changes in the last 3 months; median & sample mean vs current price

LowHigh
$570.00$748.00
Current $675.00
Median: $625.00Mean: $633.00Current: $675.00

Recent price target updates (latest 80)

  • CLSASep 3, 2026

    PT action: Announces

    $0.00 → $748.00

  • Piper SandlerJul 27, 2026

    PT action: Raises

    $510.00 → $600.00

  • Morgan StanleyJul 27, 2026

    PT action: Raises

    $620.00 → $650.00

  • RBC CapitalJul 24, 2026

    PT action: Raises

    $490.00 → $580.00

  • BarclaysJul 24, 2026

    PT action: Raises

    $625.00 → $650.00

  • Evercore ISI GroupJul 6, 2026

    PT action: Lowers

    $575.00 → $570.00

  • Piper SandlerJun 11, 2026

    PT action: Announces

    $0.00 → $510.00

  • HSBCJun 3, 2026

    PT action: Lowers

    $670.00 → $540.00

  • Wells FargoMay 8, 2026

    PT action: Lowers

    $675.00 → $615.00

  • StifelApr 24, 2026

    PT action: Lowers

    $700.00 → $600.00

  • BairdApr 24, 2026

    PT action: Lowers

    $653.00 → $639.00

  • BarclaysApr 14, 2026

    PT action: Lowers

    $650.00 → $625.00

  • Evercore ISI GroupApr 6, 2026

    PT action: Lowers

    $650.00 → $575.00

  • CitigroupJan 30, 2026

    PT action: Raises

    $660.00 → $685.00

  • TD CowenJan 30, 2026

    PT action: Lowers

    $696.00 → $683.00

  • BarclaysJan 30, 2026

    PT action: Raises

    $625.00 → $650.00

  • StifelJan 9, 2026

    PT action: Raises

    $583.00 → $700.00

  • TD CowenJan 7, 2026

    PT action: Raises

    $654.00 → $696.00

  • Wells FargoDec 15, 2025

    PT action: Raises

    $635.00 → $675.00

  • CitigroupDec 11, 2025

    PT action: Raises

    $580.00 → $660.00

Band uses only the revised target (Current column) from firm actions dated within the last 3 months—not the Prior price.

Avg Target

$653.11

Based on 27 analysts

Analyst Recommendations

Buy (24)Hold (4)Sell (1)

Upside

-3.24%

Market Cap

$249.58B

Financial & Investment Metrics

Next Earnings Date
Oct 21, 2026D-25
P/E Ratio (TTM)36.37
Forward P/E24.51
P/B Ratio4.74
Dividend Yield0.28%
Return on Equity (ROE)13.51%
Operating Margin18.75%
Debt to Equity80.58
Beta (Volatility)0.85
52 Week Range$435.27 - $682.98
LowCurrent: $675.00High

Daily editorial mentioning TMO

Price target moves

DG Faces Volatile Revisions as Eight Firms Adjust Price Targets

As of June 4, 2026, the Consumer Staples sector page reflects significant activity for Dollar General (DG), which received three upgrades and six downgrades over the past week. While Freedom Broker lifted its target to 140 from 95, other firms including Telsey Advisory and Citigroup issued downward revisions. Notably, despite this flurry of activity, the implied upside for DG remains locked at 24.9% across these specific reports.

Upgrades and downgrades

Beyond DG, analyst sentiment shifted across several sectors. Barclays notably raised its AMD target to 665 from 500, though this implies an 11.6% downside relative to recent trading. Other adjustments include:

Ticker Firm Dir Prior → Current
HON Goldman Sachs Up 258 → 276
GOOGL Piper Sandler Up 425 → 445
DHR HSBC Down 270 → 230
TMO HSBC Down 670 → 540

Limits of the data

These revisions represent individual firm outlooks and may diverge from the broader consensus mean target for each ticker. Figures reflect activity recorded through 01:45 UTC today.

Read article →

Insider Sentiment Index (Last 6 Months)

Counts and listings exclude stock awards, gifts, and option exercises—open-market purchases and sales only.

Buy vs Sell (Count)

Insider Buys: 0Insider Sells: 10

Whale Trades (C-Level Large Buys)

No major insider buying detected recently.

Recent Insider Transactions

DateNamePositionTransactionShares
8/31/2026PETTITI GIANLUCAPresidentSale at price 614.38 per share.4,133
8/24/2026CASPER MARC NChief Executive OfficerSale at price 625.41 - 628.74 per share.275
8/21/2026CASPER MARC NChief Executive OfficerSale at price 625.45 - 633.99 per share.20,000
8/19/2026BRITT LISA POfficerSale at price 613.12 per share.11,440
8/11/2026SHAFER MICHAEL DOfficerSale at price 600.00 per share.25,500
8/7/2026CASPER MARC NChief Executive OfficerSale at price 577.37 - 593.32 per share.4,883
8/7/2026HOLMES JOSEPH R.OfficerSale at price 584.81 per share.420
8/6/2026CASPER MARC NChief Executive OfficerSale at price 571.00 - 580.01 per share.15,000
8/6/2026BRITT LISA POfficerSale at price 580.00 per share.5,850
8/5/2026CASPER MARC NChief Executive OfficerSale at price 566.25 - 577.56 per share.15,000

Frequently Asked Questions

Q. What is the current target price and upside for TMO?

A. The current target price for Thermo Fisher Scientific Inc is $653.11, which implies a 3.2% downside from the current price of $675.00. This is based on the consensus of 27 Wall Street analysts.

Q. What is the current analyst recommendation for TMO?

A. Currently, there are 4 Strong Buy, 20 Buy, 4 Hold, 0 Sell, and 1 Strong Sell ratings. The overall consensus is BUY.

Q. Are insiders buying TMO stock recently?

A. Over the past 6 months, there have been 0 insider buys and 10 insider sells. Insider selling is more prominent recently.

Other Promising Stocks in Healthcare

Data provided by Yahoo Finance. This information is for informational purposes only and does not constitute investment advice. We bear no legal responsibility for any investment decisions made based on this data.

Read full disclaimer →